• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

第十三届国际血管化复合组织同种异体移植学会大会报告

Meeting Report of the 13th Congress of the International Society of Vascularized Composite Allotransplantation.

机构信息

Oxford Transplant Centre, Nuffield Department of Surgical Sciences, Oxford University Hospitals, Oxford, United Kingdom.

Department of Visceral, Transplant and Thoracic Surgery, Innsbruck Medical University, Innsbruck, Austria.

出版信息

Transplantation. 2018 Aug;102(8):1250-1252. doi: 10.1097/TP.0000000000002207.

DOI:10.1097/TP.0000000000002207
PMID:29620616
Abstract

The International Society of Vascularized Composite Allotransplantation held its 13th congress "Defining Success" in October 2017 in Salzburg, Austria. A total of 122 delegates from 22 countries representing 5 continents attended the conference. The theme strived to provide pathways to accomplish best possible outcomes in this unique and multifaceted field of transplantation. "Ignite talks," a new feature introduced for the first time at the Salzburg meeting served as key elements for productive discussions on both congress days. The "ignitors" had been selected as experts from Europe, the Americas and Asia in vascularized composite allotransplantation and neighboring disciplines and provided a global perspective of their topic. Posttransplant treatment regimens, including the most burdensome side effects of immunosuppressants in addition to novel and future therapeutic options were discussed in depth. An additional ethics symposium summarized and advanced topics that had been discussed during the first international workshop on bioethical challenges in reconstructive transplantation held earlier in 2017.

摘要

2017 年 10 月,国际血管化复合组织同种异体移植协会在奥地利萨尔茨堡举行了第 13 届大会,主题为“定义成功”。共有来自 5 大洲 22 个国家的 122 名代表参加了会议。该主题旨在为这一独特而多方面的移植领域提供实现最佳结果的途径。“点燃会谈”是萨尔茨堡会议首次推出的一个新特色,作为大会两天内富有成效讨论的关键要素。“点火者”是从血管化复合组织同种异体移植和相邻学科领域的欧洲、美洲和亚洲挑选出来的专家,他们从全球角度介绍了他们的主题。除了新的和未来的治疗选择之外,还深入讨论了移植后的治疗方案,包括免疫抑制剂最繁重的副作用。此外,还举行了一次额外的伦理研讨会,总结和推进了 2017 年初举行的第一次重建移植生物伦理挑战国际研讨会期间讨论的议题。

相似文献

1
Meeting Report of the 13th Congress of the International Society of Vascularized Composite Allotransplantation.第十三届国际血管化复合组织同种异体移植学会大会报告
Transplantation. 2018 Aug;102(8):1250-1252. doi: 10.1097/TP.0000000000002207.
2
Penile Allotransplantation for Complex Genitourinary Reconstruction.阴茎同种异体移植在复杂的泌尿生殖系统重建中的应用。
J Urol. 2017 Aug;198(2):274-280. doi: 10.1016/j.juro.2016.10.134. Epub 2017 Mar 10.
3
Existing and Evolving Bioethical Dilemmas, Challenges, and Controversies in Vascularized Composite Allotransplantation: An International Perspective From the Brocher Bioethics Working Group.血管化复合组织同种异体移植中现存和不断出现的生物伦理困境、挑战和争议:布罗谢尔生物伦理学工作组的国际视角。
Transplantation. 2019 Sep;103(9):1746-1751. doi: 10.1097/TP.0000000000002606.
4
Challenges and opportunities in vascularized composite allotransplantation of joints: a systematic literature review.关节移植的血管化复合组织异体移植的挑战和机遇:系统文献回顾。
Front Immunol. 2023 May 19;14:1179195. doi: 10.3389/fimmu.2023.1179195. eCollection 2023.
5
The Urogenital Epithelium and Corporal Tissues Are the Primary Targets of Rejection in Penile Vascularized Composite Allotransplantation: A New Real-Time Tissue-Based Monitoring System.泌尿生殖器上皮和 corporal 组织是阴茎血管化复合组织同种异体移植排斥反应的主要靶标:一种新的实时基于组织的监测系统。
Plast Reconstr Surg. 2019 Mar;143(3):534e-544e. doi: 10.1097/PRS.0000000000005377.
6
Composite tissue allotransplantation: opportunities and challenges.复合组织同种异体移植:机遇与挑战。
Cell Mol Immunol. 2019 Apr;16(4):343-349. doi: 10.1038/s41423-019-0215-3. Epub 2019 Mar 6.
7
Vascularized Composite Allotransplantation: Alternatives and Catch-22s.血管化复合组织移植:替代方案与两难处境。
Plast Reconstr Surg. 2018 Nov;142(5):1320-1326. doi: 10.1097/PRS.0000000000004855.
8
Vascularized composite allotransplantation: current standards and novel approaches to prevent acute rejection and chronic allograft deterioration.血管化复合组织异体移植:预防急性排斥反应和慢性移植物退变的现行标准及新方法
Transpl Int. 2016 Jun;29(6):655-62. doi: 10.1111/tri.12652. Epub 2015 Sep 14.
9
Genitourinary vascularized composite allotransplantation: a review of penile transplantation.泌尿系统血管化复合组织同种异体移植:阴茎移植的回顾
Curr Opin Organ Transplant. 2019 Dec;24(6):721-725. doi: 10.1097/MOT.0000000000000704.
10
Defining chronic rejection in vascularized composite allotransplantation-The American Society of Reconstructive Transplantation and International Society of Vascularized Composite Allotransplantation chronic rejection working group: 2018 American Society of Reconstructive Transplantation meeting report and white paper Research goals in defining chronic rejection in vascularized composite allotransplantation.血管化复合组织异体移植中慢性排斥反应的定义——美国重建移植学会和国际血管化复合组织异体移植学会慢性排斥反应工作组:2018年美国重建移植学会会议报告及白皮书 血管化复合组织异体移植中慢性排斥反应定义的研究目标
SAGE Open Med. 2020 Jul 14;8:2050312120940421. doi: 10.1177/2050312120940421. eCollection 2020.

引用本文的文献

1
Sensitization and Desensitization in Vascularized Composite Allotransplantation.血管化复合组织移植中的致敏与脱敏。
Front Immunol. 2021 Aug 11;12:682180. doi: 10.3389/fimmu.2021.682180. eCollection 2021.